Unlimited Liquidity as Policymakers Catch a Glimpse of the Abyss

During his testimony, Hotez, who himself developed a SARS vaccine that never reached human testing, went out of his way to ding companies for raising expectations. “Unfortunately, some of my colleagues in the biotech industry are making inflated claims,” he told the legislators. “There are a lot of press releases from the biotechs, and some of them I am not very happy about.”MIT Tech Review

As the WHO declares a global health emergency and countries around the world move to quarantine China, risk assets sold off with the S&P 500 returned -2.12% for the week. […] As long as the epidemic doesn’t deteriorate going into the second half of February forcing factory closures in China and impeding international trade, the global economic and markets outlook remains bullish, especially from 2H2020 onward.Market Update – 2 February 2020



The Textbook Sell-off Model

Weighted average monetary policy rates have hit all-time lows

30% crash in 1 month less impactful on sentiment than 20% in 3…

Putin Gifts MbS a Harsh Lesson in Realpolitik

Portfolio Strategy

I will skip this section for now. Given the fluidity of markets at this point and the fact that the Covid-19 crisis is still nowhere near under control, it would be unwise to set any sort of cyclical or secular views in stone. There will be more dislocations coming and as such, what looks like an excellent opportunity today, may look like a terrible one next week.

Tags: #markets #trading #investing #SPX #ES #equity #VIX #volatility #crash #bearmarket #bullmarket #sentiment #Fed #centralbanks #liquidity #GDP #economy #China #Russia #SaudiArabia #crudeoil #wti #covid19

Please refer to the disclaimers section for important legal notices